RLMD Stock Analysis: Buy, Sell, or Hold?
RLMD - Relmada Therapeutics, Inc. Common Stock
$7.21
0.04 (0.56%)
▲
5d:
-2.83%
30d:
+2.12%
90d:
+74.58%
BUY
HIGH Confidence
Analysis Updated: May 21, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Get Alerted When RLMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called RLMD this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: RLMD shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: RLMD shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: RLMD is currently trading at $7.21, which is considered slightly low relative to its 30-day fair value range of $7.00 to $7.55.
Technical Outlook: Technically, RLMD is in a strong uptrend. Immediate support is located at $6.17, while resistance sits at $7.67.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.80 (+77.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RLMD is in a strong uptrend. Immediate support is located at $6.17, while resistance sits at $7.67.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.80 (+77.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$7.00 -
$7.55
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 77.5% below Wall St target ($12.80)
Trading Range Analysis
30-Day Trading Range
$7.00 -
$7.55
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$6.17
Resistance Level
$7.67
Current Trend
Strong Uptrend
Technical data as of
May 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-17.59
Wall Street Target
$12.80
(+77.5%)
Share & Embed Analysis
Last updated: May 22, 2026 12:40 AM ET
Data refreshes hourly during market hours. Next update: 1:40 AM
Data refreshes hourly during market hours. Next update: 1:40 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RLMD showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Maged Shenouda
BUY
11665 shares
2025-12-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 60 HOLD |
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 50 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 58 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$109 | 59 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 53 HOLD |
